
Publication
New barriers to pharma deals: FTC challenges Amgen / Horizon merger without alleging product overlaps
The US FTC filed a lawsuit to block Amgen Inc.’s US$27.8 million acquisition of Horizon Therapeutics PLC.
We use cookies and other similar technology to collect data about you to allow us to deliver our online services, measure our website audience and improve your browsing experience. Full details on the cookies we use are set out in our Cookies policy. Please click OK to signify your consent to our use of cookies.
You can withdraw your consent by clicking “manage cookies” and following the instructions shown.
Global | Publication | March 2023
Read the full publication, "Buy Now Pay Later Regulation around the world."
Read the full publication, "2023 Annual Litigation Trends Survey results."
Publication
The US FTC filed a lawsuit to block Amgen Inc.’s US$27.8 million acquisition of Horizon Therapeutics PLC.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023